Member Exclusive

Developing iPSC-derived MSC-based therapies: an interview with Ross Macdonald, Cynata Therapeutics

In this interview from the World Stem Cell Summit (22–26 January, Miami, FL, USA), Ross Macdonald discusses the advantages of MSC-based cell therapies.

Go to the profile of RegMedNet
Mar 05, 2018

Please sign in or register for FREE

No comments yet.